Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CWK NASDAQ:MFI NYSE:PBH NYSE:PFD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWKCushman & Wakefield$16.44+0.2%$14.35$7.64▼$17.04$3.81B1.522.10 million shs2.89 million shsMFImF International$39.40+5,372.2%$0.00$4.05▼$55.60$20.89M13.3451,102 shs113,812 shsPBHPrestige Consumer Healthcare$62.97-1.0%$68.81$61.93▼$90.04$3.10B0.46417,912 shs327,035 shsPFDFlaherty & Crumrine Preferred Income Fund$12.06-0.7%$11.54$10.22▼$12.16N/AN/A29,591 shs20,037 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWKCushman & Wakefield-1.32%-1.33%+5.17%+48.13%+22.26%MFImF International-3.06%-17.62%+0.01%-18.83%+610.42%PBHPrestige Consumer Healthcare+0.81%+1.01%-4.69%-24.91%-12.88%PFDFlaherty & Crumrine Preferred Income Fund+0.54%+2.49%+5.93%+8.88%+1.68%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWKCushman & Wakefield$16.44+0.2%$14.35$7.64▼$17.04$3.81B1.522.10 million shs2.89 million shsMFImF International$39.40+5,372.2%$0.00$4.05▼$55.60$20.89M13.3451,102 shs113,812 shsPBHPrestige Consumer Healthcare$62.97-1.0%$68.81$61.93▼$90.04$3.10B0.46417,912 shs327,035 shsPFDFlaherty & Crumrine Preferred Income Fund$12.06-0.7%$11.54$10.22▼$12.16N/AN/A29,591 shs20,037 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWKCushman & Wakefield-1.32%-1.33%+5.17%+48.13%+22.26%MFImF International-3.06%-17.62%+0.01%-18.83%+610.42%PBHPrestige Consumer Healthcare+0.81%+1.01%-4.69%-24.91%-12.88%PFDFlaherty & Crumrine Preferred Income Fund+0.54%+2.49%+5.93%+8.88%+1.68%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCWKCushman & Wakefield 2.63Moderate Buy$15.13-7.97% DownsideMFImF International 0.00N/AN/AN/APBHPrestige Consumer Healthcare 2.29Hold$93.3348.21% UpsidePFDFlaherty & Crumrine Preferred Income Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CWK, MFI, PFD, DVO, and PBH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/4/2025PBHPrestige Consumer HealthcareZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell8/26/2025CWKCushman & WakefieldJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$13.00 ➝ $20.008/8/2025CWKCushman & WakefieldThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell ➝ Buy$17.508/8/2025PBHPrestige Consumer HealthcareCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$105.00 ➝ $100.008/6/2025CWKCushman & WakefieldJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$15.00 ➝ $16.007/21/2025CWKCushman & WakefieldCitizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageStrong-Buy$15.007/21/2025CWKCushman & WakefieldJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageMarket Outperform$15.007/2/2025CWKCushman & WakefieldUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$9.00 ➝ $12.00(Data available from 9/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCWKCushman & Wakefield$9.45B0.40$1.84 per share8.91$7.65 per share2.15MFImF International$3.36M6.21N/AN/A$8.80 per share4.48PBHPrestige Consumer Healthcare$1.14B2.72$5.20 per share12.10$37.04 per share1.70PFDFlaherty & Crumrine Preferred Income Fund$14.97MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCWKCushman & Wakefield$131.30M$0.8818.6811.33N/A2.11%14.33%3.41%11/3/2025 (Estimated)MFImF International-$2.60MN/A0.00∞N/AN/AN/AN/AN/APBHPrestige Consumer Healthcare$214.60M$4.2614.7813.231.9919.02%12.69%6.79%11/6/2025 (Estimated)PFDFlaherty & Crumrine Preferred Income FundN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CWK, MFI, PFD, DVO, and PBH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q1 2026PBHPrestige Consumer Healthcare$1.01$0.95-$0.06$0.95$260.71 million$249.53 million8/5/2025Q2 2025CWKCushman & Wakefield$0.22$0.30+$0.08$0.25$2.38 billion$1.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCWKCushman & WakefieldN/AN/AN/AN/AN/AMFImF InternationalN/AN/AN/AN/AN/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/APFDFlaherty & Crumrine Preferred Income Fund$0.736.06%N/AN/AN/ALatest CWK, MFI, PFD, DVO, and PBH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/23/2025PFDFlaherty & Crumrine Preferred Income Fundmonthly$0.06286.6%10/24/202510/24/202510/31/20257/23/2025PFDFlaherty & Crumrine Preferred Income Fundmonthly$0.06286.25%9/23/20259/23/20259/30/20257/23/2025PFDFlaherty & Crumrine Preferred Income Fundmonthly$0.06286.58%8/22/20258/22/20258/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCWKCushman & Wakefield1.481.131.13MFImF International0.062.002.00PBHPrestige Consumer Healthcare0.554.382.99PFDFlaherty & Crumrine Preferred Income FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCWKCushman & Wakefield95.56%MFImF InternationalN/APBHPrestige Consumer Healthcare99.95%PFDFlaherty & Crumrine Preferred Income FundN/AInsider OwnershipCompanyInsider OwnershipCWKCushman & Wakefield0.50%MFImF InternationalN/APBHPrestige Consumer Healthcare1.40%PFDFlaherty & Crumrine Preferred Income FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCWKCushman & Wakefield52,000231.53 million230.37 millionOptionableMFImF InternationalN/A530,000N/ANot OptionablePBHPrestige Consumer Healthcare54049.21 million48.53 millionOptionablePFDFlaherty & Crumrine Preferred Income FundN/AN/AN/ANot OptionableCWK, MFI, PFD, DVO, and PBH HeadlinesRecent News About These CompaniesUBS Downgrades Synovus Financial - Preferred Stock (SNV.PRE)September 3, 2025 | msn.comPFD, PFO, FFC, FLC and DFP Announce Dividends for August, September and OctoberJuly 23, 2025 | businesswire.comPFD Flaherty & Crumrine Preferred Income Fund - Seeking AlphaJuly 16, 2025 | seekingalpha.comPFD: Discounted Valuation Due To High LeverageJune 27, 2025 | seekingalpha.comRaise From DFP: Preferred Fund Pays Monthly - 7% YieldJune 2, 2025 | seekingalpha.comPFD, PFO, FFC, FLC and DFP Announce Dividends for May, June and JulyApril 16, 2025 | businesswire.comRaymond James Downgrades Synovus Financial - Preferred Stock (SNV.PRE)April 3, 2025 | msn.comRithm Capital Has 4 Preferreds: B Is My Pick NowMarch 3, 2025 | seekingalpha.comDFP: Hard To Make A Case For This Preferred FundFebruary 11, 2025 | seekingalpha.comHow To Trade (PFD)January 27, 2025 | news.stocktradersdaily.comN(PFD) Investment ReportJanuary 8, 2025 | news.stocktradersdaily.comN(PFD) Pivots Trading Plans and Risk ControlsDecember 17, 2024 | news.stocktradersdaily.comNWhen the Price of (PFD) Talks, People ListenDecember 6, 2024 | news.stocktradersdaily.comNBEPR:CA Brompton Flaherty & Crumrine Enhanced Investment Grade Preferred ETFNovember 28, 2024 | seekingalpha.com(PFD) Trading ReportNovember 25, 2024 | news.stocktradersdaily.comNLong Term Trading Analysis for (PFD)November 4, 2024 | news.stocktradersdaily.comNBrompton Funds Announces Termination of Distribution Reinvestment Plan for Its Exchange Traded FundsOctober 31, 2024 | markets.businessinsider.comDestra Flaherty & Crumrine Preferred And Income Fund Class A (0P0000SGBZ)October 28, 2024 | uk.investing.comTrading (PFD) With Integrated Risk ControlsOctober 23, 2024 | news.stocktradersdaily.comNFlaherty & Crumrine Preferred and Income Securities Fund Incorporated raises monthly dividend by 2.6% to $0.092/shareOctober 18, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCWK, MFI, PFD, DVO, and PBH Company DescriptionsCushman & Wakefield NYSE:CWK$16.43 +0.03 (+0.15%) Closing price 03:59 PM EasternExtended Trading$16.42 -0.02 (-0.12%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America. The EMEA segment includes operations in the UK, France, Netherlands and other markets in Europe and the Middle East. The APAC segment comprises of operations in Australia, Singapore, China and other markets in the Asia Pacific region. The company was founded in 1917 and is headquartered in London, the United Kingdom.mF International NASDAQ:MFIMicroFinancial Incorporated (MicroFinancial) operates through its wholly-owned subsidiaries, TimePayment Corp. (TimePayment) and Leasecomm Corporation (Leasecomm). TimePayment is a specialized commercial/consumer finance company that leases and rents equipment, and provides other financing services, with a focus on the microticket market. TimePayment finances a variety of products, including water filtration systems, food service equipment, security equipment, point of sale (POS) cash registers, salon equipment, copiers, health care and fitness equipment, and automotive repair equipment. The Company provides financing alternatives to a range of lessees ranging from start-up businesses to established enterprises.Prestige Consumer Healthcare NYSE:PBH$62.97 -0.63 (-0.98%) Closing price 03:59 PM EasternExtended Trading$62.99 +0.02 (+0.03%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.Flaherty & Crumrine Preferred Income Fund NYSE:PFD$12.06 -0.09 (-0.70%) Closing price 03:55 PM EasternExtended Trading$12.06 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Flaherty & Crumrine Preferred Income Fund Inc. is a closed ended equity mutual fund launched and managed by Flaherty & Crumrine Incorporated. The fund invests in the public equity markets of the United States. It invests in the stocks of companies operating in the financials sector. The fund primarily invests in preferred securities. It benchmarks the performance of its portfolio against the Barclays Capital U.S. Aggregate Index and S&P 500 Index. Flaherty & Crumrine Preferred Income Fund Inc was formed on September 28, 1990 and is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 High-Yields at 52-Week Lows: Buy, Sell, or Hold Advance Auto Parts is A Great Risk/Reward Play If EPS Delivers 3 Small Caps That Insiders Are Buying Amprius Technologies: Anatomy of a Textbook, Raging Bull Market Banks Boost Gold Forecasts: One Sees +30% Bull-Case Potential These 3 Stocks Boosting Buybacks Have Rallying Potential GameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound? Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
